Treatment | Proportion (%) of patients who found daily activities to be ‘no more difficult than normal’ after treatment | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 h | p-value | 2 h | p-value | 3 h | p-value | 4 h | p-value | |||||
All headache episodes | ||||||||||||
AAC (n = 2734 – 2736 over 1 h – 4 h) | 30.2 | AAC vs. P | 0.0001 | 47.8 | AAC vs. P | <0.0001 | 64.8 | AAC vs. P | <0.0001 | 76.1 | AAC vs. P | <0.0001 |
APAP (n = 2738 – 2747 over 1 h – 4 h) | 25.8 | A vs. P | 0.16 | 41.3 | A vs. P | 0.016 | 57.7 | A vs. P | <0.0001 | 69.6 | A vs. P | <0.0001 |
Placebo (n = 1367 – 1375 over 1 h – 4 h) | 22.8 | AAC vs. A | 0.0005 | 36.3 | AAC vs. A | <0.0001 | 51.0 | AAC vs. A | <0.0001 | 60.9 | AAC vs. A | <0.0001 |
Severe at baseline | ||||||||||||
AAC (n = 856 – 858 over 1 h – 4 h) | 17.1 | AAC vs. P | 0.18 | 31.1 | AAC vs. P | 0.079 | 48.1 | AAC vs. P | 0.0001 | 62.5 | AAC vs. P | <0.0001 |
APAP (n = 897 – 901 over 1 h – 4 h) | 13.4 | A vs. P | 0.93 | 27.2 | A vs. P | 0.60 | 43.1 | A vs. P | 0.046 | 56.5 | A vs. P | 0.032 |
Placebo (n = 453 – 456 over 1 h – 4 h) | 10.5 | AAC vs. A | 0.033 | 20.4 | AAC vs. A | 0.082 | 34.0 | AAC vs. A | 0.011 | 45.7 | AAC vs. A | 0.002 |